BRIEF-Jazz Pharmaceuticals Q4 Adjusted EPS USD 6.6 Vs. IBES Estimate USD 5.81

Reuters
26 Feb
BRIEF-Jazz Pharmaceuticals Q4 Adjusted EPS USD 6.6 Vs. IBES Estimate USD 5.81

Feb 25 (Reuters) - Jazz Pharmaceuticals Q4 net income USD 191.115 million.

  • Q4 adjusted net income USD 405.863 million vs. IBES estimate USD 369.9 million
  • Q4 revenue USD 1,088.173 million vs. IBES estimate USD 1,060 million
  • Q4 EPS USD 3.11

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10